Monday, The FDA approves the Pfizer-Bioentech Covid-19 vaccine Children aged 12-15 years, And the CDC’s Advisory Committee on Vaccination Practice is ready to vote on it at this age on Wednesday. It comes at a time when the epidemic is spreading beyond our borders and when many adult children in Asia, Latin America and Africa remain unaccounted for. It has already started a debate. This is a false equivalent and a unproductive conversation, likely to help both adults and children.
Yes, it is true that children rarely die from Kovid-19 (although some do). Yes, it is true that most children do not get hospitalized for Covid-19 (although many, especially those with preventive or other underlying conditions). Older children are infected with SARS-Cavi-2 at the same rate as adults, and new data this week show children’s accounting 24 percent of all new infections in the United States (More than 2 percent in April 2020) probably due to the success of our vaccination program among adults. A big unknown is whether children will be affected by the long-term consequences of the infection (later post-acute scoliosis) by the usually mild symptoms in the acute phase. We know that a small minority of children develop multisystem inflammatory syndrome, which can be fatal. In any case of covid-related, however, it is higher than the rate of infection and death. The impact of mental health on children and adolescents is documented as the loss of their education and the exit of women with children from the workforce. These are big problems that we have not yet begun to solve.
As a working parent with three healthy kids (one vaccinated, one newly eligible and one not yet eligible) with comfortable income, good internet access and local schools following the science-based Covid-19 protocol, it must be tempting to think my 15-year-old vaccine dose would be better elsewhere. Please. Is this actually a useful question? As a starting point, for example, the Pfizer-Bioentech vaccine is not currently approved for use in India, although it may change. We know that India needs oxygen, PPE and other medical supplies, and there are many ways that Americans can and do contribute to this effort. The Lancet Covid-19 Commission India Task Force has called for various measures to transition, among other things, Promote vaccination of 5 million doses per day Targeting people over the age of 45. They estimate that India can meet half of its current production targets, if financial resources and raw materials are provided, with significantly increased potential. The effort could lead to far greater long-term benefits for India than the four-day low-cost Pfizer-Bioentech vaccine (five million doses per day) if 117 million 12-15-year-olds in the United States drop out of the vaccine.
The Biden administration on April 26 released a fact sheet outlining the emergency Covid-19 assistance to India, which outlines সহায় 100 million in assistanceFurther, including the production supply of AstraZeneca vaccines, the US Still keep a stock Among the AstraZeneca vaccines, there is never a possibility of approval here, and they should be administered in countries that can now use them instead of on the left. Many have criticized the administration’s response as inadequate, especially considering the intellectual property for the Kovid-19 vaccine. These are important discussions that should be at the top of the news report. Fictional moral discussion and a quote on Twitter from the head of some public health affairs related to the vaccine for children. Of course children should be vaccinated. And of course the United States should do so to facilitate global access to vaccines.
As a pediatric HIV specialist, I have seen children place at the end of the line and repeatedly when it comes to approving life-saving HIV drugs. In fact, the biggest immediate breakthrough in pediatric HIV came when a courageous physician in Mississippi opted for a guideline-guided non-procedure. Caring for a newborn, Desperate to try to prevent HIV infection. “In this caseMississippi Baby“Leads to numerous clinical trials and transmits new research methods to cure HIV in children.